Sepsis and cirrhosis: Many similarities

Acta Gastro-Enterologica Belgica

Volumn 73, Issue 4, 2010, Pages 472-478

  Vincent, J L ^a   Gustot, T ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

Cardiac output; Coagulation; Corticosteroids; Cytokines; Encephalopathy; Inflammation; Lactate; Renal failure; Respiratory failure; Shock; Vasopressin

Indexed keywords

ALBUMIN; ANTIBIOTIC AGENT; CYTOKINE; DOPAMINE; FLUDROCORTISONE; HETASTARCH; HLA DR ANTIGEN; HYDROCORTISONE; NORADRENALIN; THROMBOPLASTIN; TOLL LIKE RECEPTOR; VASOPRESSIN;

ANTIBIOTIC THERAPY; ANTIGEN EXPRESSION; BACTERIAL INFECTION; BACTERIAL PERITONITIS; BRAIN DISEASE; CYTOKINE RELEASE; DISEASE ASSOCIATION; DISSEMINATED INTRAVASCULAR CLOTTING; FLUID THERAPY; HEART ARRHYTHMIA; HOSPITAL INFECTION; HUMAN; HYPOXEMIA; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOMODULATION; INFECTION CONTROL; INFLAMMATION; KIDNEY DYSFUNCTION; LIVER CIRRHOSIS; LIVER DYSFUNCTION; MICROBIAL GROWTH; OLIGURIA; PNEUMONIA; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEPSIS; URINARY TRACT INFECTION; VASOPRESSIN RELEASE; MULTIPLE ORGAN FAILURE; PATHOPHYSIOLOGY;

HUMANS; LIVER CIRRHOSIS; MULTIPLE ORGAN FAILURE; SEPSIS;

EID: 79952134883     PISSN: 00015644     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (60)

1. LEVY M.M., FINK M.P., MARSHALL J.C., ABRAHAM E., ANGUS D., COOK D., COHEN J., OPAL S.M., VINCENT J.L., RAMSAY G., 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit. Care Med., 2003, 31: 1250-6.
2. GARCIA-TSAO G., FRIEDMAN S., IREDALE J., PINZANI M. Now there are many (stages) where before there was one: In search of a pathophysiological classification of cirrhosis. Hepatology, 2010, 51: 1445-9.
3. HOTCHKISS R.S., KARL I.E. The pathophysiology and treatment of sepsis. N. Engl. J. Med., 2003, 348: 138-50.
4. FOSTER S.L., HARGREAVES D.C., MEDZHITOV R. Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature, 2007, 447: 972-8.
5. HOTCHKISS R.S., TINSLEY K.W., SWANSON P.E., SCHMIEG R.E., JR., HUI J.J., CHANG K.C., OSBORNE D.F., FREEMAN B.D., COBB J.P., BUCHMAN T.G., KARL I.E. Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans. J. Immunol., 2001, 166: 6952-63.
6. HOTCHKISS R.S., CHANG K.C., SWANSON P.E., TINSLEY K.W., HUI J.J., KLENDER P., XANTHOUDAKIS S., ROY S., BLACK C., GRIMM E., ASPIOTIS R., HAN Y., NICHOLSON D.W., KARL I.E. Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte. Nat. Immunol., 2000, 1: 496-501.
7. PIAGNERELLI M., BOUDJELTIA K.Z., VANHAEVERBEEK M., VINCENT J.L. Red blood cell rheology in sepsis. Intensive Care Med., 2003, 29: 1052-61.
8. DE BACKER D., CRETEUR J., PREISER J.C., DUBOIS M.J., VINCENT J.L. Microvascular blood flow is altered in patients with sepsis. Am. J. Respir. Crit Care Med., 2002, 166: 98-104.
9. VINCENT J.L., MORENO R., TAKALA J., WILLATTS S., DE MENDONCA A., BRUINING H., REINHART C.K., SUTER P.M., THIJS L.G. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med., 1996, 22: 707-10.
10. ANNANE D., SEBILLE V., TROCHE G., RAPHAEL J.C., GAJDOS P., BELLISSANT E. A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA, 2000, 283: 1038-45.
11. ANNANE D., SEBILLE V., CHARPENTIER C., BOLLAERT P.E., FRANCOIS B., KORACH J.M., CAPELLIER G., COHEN Y., AZOULAY E., TROCHE G., CHAUMET-RIFFAUD P., BELLISSANT E. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA, 2002, 288: 862-71.
12. SPRUNG C.L., ANNANE D., KEH D., MORENO R., SINGER M., FREIVOGEL K., WEISS Y.G., BENBENISHTY J., KALENKA A., FORST H., LATERRE P.F., REINHART K., CUTHBERTSON B.H., PAYEN D., BRIEGEL J. Hydrocortisone therapy for patients with septic shock. N. Engl. J. Med., 2008, 358: 111-24.
13. DELLINGER R.P., LEVY M.M., CARLET J.M., BION J., PARKER M.M., JAESCHKE R., REINHART K., ANGUS D.C., BRUN-BUISSON C., BEALE R., CALANDRA T., DHAINAUT J.F., GERLACH H., HARVEY M., MARINI J.J., MARSHALL J., RANIERI M., RAMSAY G., SEVRANSKY J., THOMPSON B.T., TOWNSEND S., VENDER J.S., ZIMMERMAN J.L., VINCENT J.L. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med., 2008, 36: 296-327.
14. LANDRY D.W., LEVIN H.R., GALLANT E.M., ASHTON R.C., JR., SEO S., D'ALESSANDRO D., OZ M.C., OLIVER J.A. Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation, 1997, 95: 1122-5.
15. RUSSELL J.A., WALLEY K.R., SINGER J., GORDON A.C., HEBERT P.C., COOPER D.J., HOLMES C.L., MEHTA S., GRANTON J.T., STORMS M.M., COOK D.J., PRESNEILL J.J., AYERS D. Vasopressin versus norepinephrine infusion in patients with septic shock. N. Engl. J. Med., 2008, 358: 877-87.
16. BORZIO M., SALERNO F., PIANTONI L., CAZZANIGA M., ANGELI P., BISSOLI F., BOCCIA S., COLLOREDOMELS G., CORIGLIANO P., FORNACIARI G., MARENCO G., PISTARA R., SALVAGNINI M., SANGIOVANNI A. Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study. Dig. Liver Dis., 2001, 33: 41-8.
17. GUSTOT T., DURAND F., LEBREC D., VINCENT J.L., MOREAU R. Severe sepsis in cirrhosis. Hepatology, 2009, 50: 2022-33.
18. HOMANN C., VARMING K., HOGASEN K., MOLLNES T.E., GRAUDAL N., THOMSEN A.C., GARRED P. Acquired C3 deficiency in patients with alcoholic cirrhosis predisposes to infection and increased mortality. Gut, 1997, 40: 544-9.
19. WASMUTH H.E., KUNZ D., YAGMUR E., TIMMERSTRANGHONER A., VIDACEK D., SIEWERT E., BACH J., GEIER A., PURUCKER E.A., GRESSNER A.M., MATERN S., LAMMERT F. Patients with acute on chronic liver failure display sepsis-like immune paralysis. J. Hepatol., 2005, 42:, 195-201.
20. GOMEZ F., RUIZ P., SCHREIBER A.D. Impaired function of macrophage Fc gamma receptors and bacterial infection in alcoholic cirrhosis. N. Engl. J. Med., 1994, 331: 1122-8.
21. RAJKOVIC I.A., WILLIAMS R. Abnormalities of neutrophil phagocytosis, intracellular killing and metabolic activity in alcoholic cirrhosis and hepatitis. Hepatology, 1986, 6: 252-62.
22. BYL B., ROUCLOUX I., CRUSIAUX A., DUPONT E., DEVIERE J. Tumor necrosis factor alpha and interleukin 6 plasma levels in infected cirrhotic patients. Gastroenterology, 1993, 104: 1492-7.
23. GALBOIS A., THABUT D., TAZI K.A., RUDLER M., MOHAMMADI M.S., BONNEFONT-ROUSSELOT D., BENNANI H., BEZEAUD A., TELLIER Z., GUICHARD C., COANT N., OGIERDENIS E., MOREAU R., LEBREC D. Ex vivo effects of high-density lipoprotein exposure on the lipopolysaccharide-induced inflammatory response in patients with severe cirrhosis. Hepatology, 2009, 49: 175-84.
24. TAZI K.A., QUIOC J.J., SAADA V., BEZEAUD A., LEBREC D., MOREAU R. Upregulation of TNF-alpha production signaling pathways in monocytes from patients with advanced cirrhosis: possible role of Akt and IRAK-M. J. Hepatol., 2006, 45: 280-9.
25. GUSTOT T., RUDLER M., COANT N., GANDOURA S., GUICHARD C., ABDEL-RAZEK W. Unrestricted constitutive activity of glycogen synthase kinase 3 (GSK3) inhibits anti-inflammatory cytokine production in LPSstimulated immune cells from patients with advanced cirrhosis. Hepatology, 2009, 50 (Suppl 4): 873A (abstr).
26. LE MOINE O., MARCHANT A., DE GROOTE D., AZAR C., GOLDMAN M., DEVIERE J. Role of defective monocyte interleukin-10 release in tumor necrosis factor-alpha overproduction in alcoholics cirrhosis. Hepatology, 1995, 22: 1436-9.
27. LEMMERS A., MORENO C., GUSTOT T., MARECHAL R., DEGRE D., DEMETTER P., DE NADAI P., GEERTS A., QUERTINMONT E., VERCRUYSSE V., LE MOINE O., DEVIERE J. The interleukin-17 pathway is involved in human alcoholic liver disease. Hepatology, 2009, 49: 646-57.
28. PLESSIER A., DENNINGER M.H., CONSIGNY Y., PESSIONE F., FRANCOZ C., DURAND F., FRANCQUE S., BEZEAUD A., CHAUVELOT-MOACHON L., LEBREC D., VALLA D.C., MOREAU R. Coagulation disorders in patients with cirrhosis and severe sepsis. Liver Int., 2003, 23: 440-8.
29. FERNANDEZ J., NAVASA M., GOMEZ J., COLMENERO J., VILA J., ARROYO V., RODES J. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology, 2002, 35: 140-8.
30. FOREMAN M.G., MANNINO D.M., MOSS M. Cirrhosis as a risk factor for sepsis and death: analysis of the National Hospital Discharge Survey. Chest, 2003, 124: 1016-20.
31. FEIKIN D.R., SCHUCHAT A., KOLCZAK M., BARRETT N.L., HARRISON L.H., LEFKOWITZ L., MCGEER A., FARLEY M.M., VUGIA D.J., LEXAU C., STEFONEK K.R., PATTERSON J.E., JORGENSEN J.H. Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997. Am. J. Public Health, 2000, 90: 223-9.
32. WEHLER M., KOKOSKA J., REULBACH U., HAHN E.G., STRAUSS R. Short-term prognosis in critically ill patients with cirrhosis assessed by prognostic scoring systems. Hepatology, 2001, 34: 255-61.
33. WALLAERT B., COLOMBEL J.F., PRIN L., SIBILLE Y., TONNEL A.B. Bronchoalveolar lavage in alcoholic liver cirrhosis. T-lymphocyte subsets and immunoglobulin concentrations. Chest, 1992, 101: 468-73.
34. CHANG S.W., OHARA N. Chronic biliary obstruction induces pulmonary intravascular phagocytosis and endotoxin sensitivity in rats. J. Clin. Invest., 1994, 94:, 2009-19.
35. MATUSCHAK G.M. Lung-liver interactions in sepsis and multiple organ failure syndrome. Clin. Chest Med., 1996, 17: 83-98.
36. MONCHI M., BELLENFANT F., CARIOU A., JOLY L.M., THEBERT D., LAURENT I., DHAINAUT J.F., BRUNET F. Early predictive factors of survival in the acute respiratory distress syndrome. A multivariate analysis. Am. J Respir. Crit Care Med., 1998, 158: 1076-81.
37. RABE C., SCHMITZ V., PAASHAUS M., MUSCH A., ZICKERMANN H., DUMOULIN F.L., SAUERBRUCH T., CASELMANN W.H. Does intubation really equal death in cirrhotic patients? Factors influencing outcome in patients with liver cirrhosis requiring mechanical ventilation. Intensive Care Med., 2004, 30: 1564-71.
38. RUIZ-DEL-ARBOL L., MONESCILLO A., AROCENA C., VALER P., GINES P., MOREIRA V., MILICUA J.M., JIMENEZ W., ARROYO V. Circulatory function and hepatorenal syndrome in cirrhosis. Hepatology, 2005, 42: 439-47.
39. ASTER R.H. Pooling of platelets in the spleen: role in the pathogenesis of hypersplenic thrombocytopenia. J. Clin. Invest., 1966, 45: 645-57.
40. LISMAN T., BONGERS T.N., ADELMEIJER J., JANSSEN H.L., DE MAAT M.P., DE GROOT P.G., LEEBEEK F.W. Elevated levels of von Willebrand Factor in cirrhosis support platelet adhesion despite reduced functional capacity. Hepatology, 2006, 44: 53-61.
41. WRIGHT G., DAVIES N.A., SHAWCROSS D.L., HODGES S.J., ZWINGMANN C., BROOKS H.F., MANI A.R., HARRY D., STADLBAUER V., ZOU Z., WILLIAMS R., DAVIES C., MOORE K.P., JALAN R. Endotoxemia produces coma and brain swelling in bile duct ligated rats. Hepatology, 2007, 45: 1517-26.
42. RUIZ-DEL-ARBOL L., URMAN J., FERNANDEZ J., GONZALEZ M., NAVASA M., MONESCILLO A., ALBILLOS A., JIMENEZ W., ARROYO V. Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis. Hepatology, 2003, 38: 1210-8.
43. ALQAHTANI S.A., FOUAD T.R., LEE S.S. Cirrhotic cardiomyopathy. Semin. Liver Dis., 2008, 28: 59-69.
44. TSAI M.H., PENG Y.S., CHEN Y.C., LIU N.J., HO Y.P., FANG J.T., LIEN J.M., YANG C., CHEN P.C., WU C.S. Adrenal insufficiency in patients with cirrhosis, severe sepsis and septic shock. Hepatology, 2006, 43: 673-81.
45. PETRIDES A.S., VOGT C., SCHULZ-EBERGE D., MATTHEWS D., STROHMEYER G. Pathogenesis of glucose intolerance and diabetes mellitus in cirrhosis. Hepatology, 1994, 19: 616-27.
46. KUMAR A., ROBERTS D., WOOD K.E., LIGHT B., PARRILLO J.E., SHARMA S., SUPPES R., FEINSTEIN D., ZANOTTI S., TAIBERG L., GURKA D., KUMAR A., CHEANG M. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med., 2006, 34: 1589-96.
47. RIMOLA A., GARCIA-TSAO G., NAVASA M., PIDDOCK L.J., PLANAS R., BERNARD B., INADOMI J.M. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club. J. Hepatol., 2000, 32: 142-53.
48. VINCENT J.L., GERLACH H. Fluid resuscitation in severe sepsis and septic shock: an evidence-based review. Crit Care Med., 2004, 32: S451-S454.
49. FINFER S., BELLOMO R., BOYCE N., FRENCH J., MYBURGH J., NORTON R. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N. Engl. J. Med., 2004, 350: 2247-56.
50. SORT P., NAVASA M., ARROYO V., ALDEGUER X., PLANAS R., RUIZ-DEL-ARBOL L., CASTELLS L., VARGAS V., SORIANO G., GUEVARA M., GINES P., RODES J. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N. Engl. J. Med., 1999, 341: 403-9.
51. LEGENDRE C., THERVET E., PAGE B., PERCHERON A., NOEL L.H., KREIS H. Hydroxyethylstarch and osmotic-nephrosis-like lesions in kidney transplantation. Lancet, 1993, 342: 248-9.
52. BRUNKHORST F.M., ENGEL C., BLOOS F., MEIER-HELLMANN A., RAGALLER M., WEILER N., MOERER O., GRUENDLING M., OPPERT M., GROND S., OLTHOFF D., JASCHINSKI U., JOHN S., ROSSAINT R., WELTE T., SCHAEFER M., KERN P., KUHNT E., KIEHNTOPF M., HARTOG C., NATANSON C., LOEFFLER M., REINHART K. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N. Engl. J. Med., 2008, 358: 125-39.
53. FERNANDEZ J., MONTEAGUDO J., BARGALLO X., JIMENEZ W., BOSCH J., ARROYO V., NAVASA M. A randomized unblinded pilot study comparing albumin versus hydroxyethyl starch in spontaneous bacterial peritonitis. Hepatology, 2005, 42: 627-34.
54. DE BACKER D., BISTON P., DEVRIENDT J., MADL C., CHOCHRAD D., ALDECOA C., BRASSEUR A., DEFRANCE P., GOTTIGNIES P., VINCENT J.L. Comparison of dopamine and norepinephrine in the treatment of shock. N. Engl. J. Med. 2010, 362: 779-89.
55. ANNANE D., VIGNON P., RENAULT A., BOLLAERT P.E., CHARPENTIER C., MARTIN C., TROCHE G., RICARD J.D., NITENBERG G., PAPAZIAN L., AZOULAY E., BELLISSANT E. Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial. Lancet, 2007, 370: 676-84.
56. LEVY B., BOLLAERT P.E., CHARPENTIER C., NACE L., AUDIBERT G., BAUER P., NABET P., LARCAN A. Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock: a prospective, randomized study. Intensive Care Med., 1997, 23: 282-7.
57. BERNARD G.R., VINCENT J.L., LATERRE P.F., LAROSA S.P., DHAINAUT J.F., LOPEZ-RODRIGUEZ A., STEINGRUB J.S., GARBER G.E., HELTERBRAND J.D., ELY E.W., FISHER C.J., JR. Efficacy and safety of recombinant human activated protein C for severe sepsis. N. Engl. J. Med., 2001, 344: 699-709.
58. ABRAHAM E., LATERRE P.F., GARG R., LEVY H., TALWAR D., TRZASKOMA B.L., FRANCOIS B., GUY J.S., BRUCKMANN M., REA-NETO A., ROSSAINT R., PERROTIN D., SABLOTZKI A., ARKINS N., UTTERBACK B.G., MACIAS W.L. Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death. N. Engl. J. Med., 2005, 353: 1332-41.
59. FRANCOZ C., BELGHITI J., VILGRAIN V., SOMMACALE D., PARADIS V., CONDAT B., DENNINGER M.H., SAUVANET A., VALLA D., DURAND F. Splanchnic vein thrombosis in candidates for liver trans plantation: usefulness of screening and anticoagulation. Gut, 2005, 54: 691-7.
60. FERNANDEZ J., ESCORSELL A., ZABALZA M., FELIPE V., NAVASA M., MAS A., LACY A.M., GINES P., ARROYO V. Adrenal insufficiency in patients with cirrhosis and septic shock: Effect of treatment with hydrocortisone on survival. Hepatology, 2006, 44: 1288-95.